| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VENUS ACQUISITION CORPORATIO | 4 | Q3 2022 | 9.4% |
| LMF ACQUISITION OPPORTUNIT I | 3 | Q2 2022 | 10.9% |
| GOLDENBRIDGE ACQUISITION LTD | 3 | Q2 2022 | 10.9% |
| MODEL PERFORMANCE ACQU CORP | 3 | Q2 2022 | 9.4% |
| PROGRESS ACQUISITION CORP | 3 | Q2 2022 | 7.8% |
| FOXWAYNE ENTERPRIS AQSTN COR | 3 | Q2 2022 | 7.8% |
| SURROZEN INC | 3 | Q2 2022 | 6.2% |
| IBERE PHARMACEUTICALS | 3 | Q2 2022 | 4.7% |
| AGBA ACQUISITION LTD | 3 | Q2 2022 | 4.7% |
| EDOC ACQUISITION CORP | 3 | Q2 2022 | 3.1% |
View Integrity Capital Management (HK) Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-10-07 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-04-26 |
| 13F-HR | 2022-02-11 |
View Integrity Capital Management (HK) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.